🔗 Share this article

A shadow market for unlicensed slimming medications is propelled by social media fitness personalities and vendors on messaging platforms, according to new investigations.

Experimental Drug Gaining Traction Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to contact these accounts privately for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing customers to other platforms for purchases.

Understanding Retatrutide

Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials suggest it could help patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and chemists have cautions that the distribution of what remains an unapproved drug in the UK is worrisome and could result in individuals injecting products of unknown origin.

Several professionals stated the demand for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Some content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer regulations, risking penalties, prosecution or prison.

Service Response and Content Removal

Based on TikTok, the service has removed problematic material and prohibited associated hashtags and query recommendations. The organization said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.

Online Marketplace Activities

Research also found groups with up to 9,000 members selling the experimental drug using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of members, populated with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.

After moments of entering one group, a seller shared contact information, where most purchases occur. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about body mass, health issues or past usage.

Item Information and Pricing

Within these groups, messages show black plastic packages with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with purified liquid, or ready-to-use injectors typically sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.

Platform Oversight and Security Actions

A spokesperson for the messaging service said it actively monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting materials they cannot confirm. Even if the science behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor linked the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But fake injections are highly risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.

Her team has already seen patients injured by self-injection from unconfirmed sources. “We recognize the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” stated the doctor. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, noting that any item “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially significant health risks”.